Skip to content

Total debt at other companies

Insulet logo
InsuletPODD
$969.7M-45.5%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$734.74M+49.0%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$156.93M+1,310%
Mannkind logo
MannkindMNKD
$12.24M-9.4%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
$6.91M-0.9%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

Plus components not separately reported this period.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s total debt?
Embecta Corp. (EMBC) reported total debt of $1.37B in Q1 2026.
How has Embecta Corp.'s total debt changed year-over-year?
Embecta Corp.'s total debt decreased by 12.5% year-over-year, from $1.57B to $1.37B.
What is the long-term trend for Embecta Corp.'s total debt?
Over 4 years (2021 to 2025), Embecta Corp.'s total debt has grown at a 333.5% compound annual growth rate (CAGR), from $4.1M to $1.45B.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.